Biomarcadores de las Enfermedades Cardíacas
BIOMARCS
University of Hull
Kingston upon Hull, Reino UnidoPublicacións en colaboración con investigadores/as de University of Hull (2)
2022
-
Biomarker-based assessment of collagen cross-linking identifies patients at risk of heart failure more likely to benefit from spironolactone effects on left atrial remodelling. Insights from the HOMAGE clinical trial
European Journal of Heart Failure, Vol. 24, Núm. 2, pp. 321-331